Status:
COMPLETED
Investigation of the Skin Barrier in Patients With Type 1 Diabetes
Lead Sponsor:
Jannet Svensson
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
2+ years
Brief Summary
This study is a case-control study comparing the skin barrier between 50 T1D patients with healthy controls in 3 age-strata including both pediatric and adult patients.
Detailed Description
The skin is a crucial barrier against external allergens and irritants. Therefore the function of the skin barrier is central regarding evolvement of eczema. In patients with type 1 diabetes (T1D) usi...
Eligibility Criteria
Inclusion
- Cases:
- Diagnosed with type 1 diabetes, more than 6 months ago
Exclusion
- Skin lesions at both buttocks and forearms so investigation can not be done
- Known skin diseases with decreased barrier function like atopic dermatitis, psoriasis and allergic contact dermatitis
- Active infectious disease
- Use of immunosuppressive medication e.g. steroids
- Lack of language competence in Danish
- Controls:
- Inclusion Criteria:
- Diagnosed with Tourettes or Headache OR sibling for patients in the 1813-clinic at Pediatric Emergency Toom OR Hospitalized patients at Pediatric department OR Parents to alle these
- Exclusion Criteria are equal to exclusion criteria in cases
Key Trial Info
Start Date :
February 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 14 2021
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT04280315
Start Date
February 18 2020
End Date
June 14 2021
Last Update
February 3 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Steno Diabetes Center Copenhagen
Gentofte Municipality, Capital Region, Denmark, 2820
2
Department of Pediatrics, Herlev Hospital
Herlev, Capital Region, Denmark, 2730